Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

David Cunningham, William Allum, Sally Stenning et al. · New England Journal of Medicine · 2006 · 6.4K citations

Medicine, Oncology, Surgery +12

TNM Classification of Malignant Tumors

Darryl Carter · The American Journal of Surgical Pathology · 1998 · 6.4K citations

Veterinary Medicine, Oncology, Pathology +14

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

David Cunningham, Naureen Starling, Sheela Rao et al. · New England Journal of Medicine · 2008 · 2.3K citations

Medicine, Oncology, Pharmacology +12

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

Marc Ychou, Valérie Boige, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2011 · 2.1K citations · Full text

Medicine, Oncology, Surgery +9

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2006 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +11